BackPhio Pharmaceuticals - Warrants (21/12/2021) Overview

Phio Pharmaceuticals - Warrants (21/12/2021) Common Stock

Phio Pharmaceuticals - Warrants (21/12/2021)'s common stock is $1K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$1000.00

Peer trimmed avg / median

Loading

Phio Pharmaceuticals - Warrants (21/12/2021) Common Stock History

Loading

Phio Pharmaceuticals - Warrants (21/12/2021) vs. peers: Common Stock Comparison

Loading

Phio Pharmaceuticals - Warrants (21/12/2021) Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Phio Pharmaceuticals - Warrants (21/12/2021) (PHIOW) FAQ

As of the most recent data (June 2026), PHIOW shows a common stock of $1K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHIOW's common stock is now $1K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Phio Pharmaceuticals - Warrants (21/12/2021) is outperforming or lagging.

Tracking PHIOW's common stock over time shows whether Phio Pharmaceuticals - Warrants (21/12/2021) is scaling, shrinking, or reshaping that part of the business. The current reading is $1K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Phio Pharmaceuticals - Warrants (21/12/2021)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1K) with ownership activity and broader fundamentals.

Phio Pharmaceuticals - Warrants (21/12/2021)'s common stock is $1K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.